Feligen® RCP
Active substance
ATC code
Species
Cats.
Indications
The vaccine is intended for the active immunisation of healthy cats of minimum 9 weeks of age against:
- feline calicivirosis and feline viral rhinotracheitis to reduce clinical signs and viral excretion;
- feline panleucopenia to prevent leucopenia and to reduce clinical signs.
Onset of immunity is established four weeks after vaccination for calici virus and rhinotracheitis and three weeks for panleucopenia virus. This immunity lasts for 12 months.
Dose to be administered and administration route
Shake gently the vial after reconstitution of the freeze-dried component in the diluent. Administer immediately via the subcutaneous route 1 dose of Feligen® RCP according to the following regimen of vaccination.
- Basic vaccination scheme:
- a first injection into cats from minimum 9 weeks of age; - a second injection 3 to 4 weeks later.
- Maternally derived antibodies can negatively influence the immune response to vaccination.
- In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age.
- Re-vaccination scheme: annual re-vaccination of cats
Adverse reactions
Some transient post-vaccinal digestive disturbances were very commonly observed in safety studies. A slight and transient oedema which disappears spontaneously within 2 days was commonly observed during the days following vaccination in safety studies. Some transient and self-resolving post-vaccinal signs such as a slight hyperthermia and lethargy were commonly observed in safety studies.
Hypersensitivity reactions (e.g. emesis, diarrhoea, dyspnoea, allergic oedema) have been reported in very rare cases from spontaneous reports.
In case of such an allergic or anaphylactic reaction, appropriate symptomatic treatment should be administered.
As reported in the literature, after the use of any vaccine containing a Feline Calicivirus component, febrile limping syndrome reactions may occur very rarely in kittens.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
